Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (391-400 of 525) with videos related to

Pageof 53
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Xin Li, Bruce J Trock, et al.
Angewandte Chemie (International Ed. in English)|July 28, 2015
Synthesis and Evaluation of Gd(III) -Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane AntigenSangeeta Ray Banerjee, Ethel J Ngen, Matthew W Rotz, et al.
Molecules (Basel, Switzerland)|April 5, 2020
In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [<sup>125</sup>I]Iodo-ASEM and [<sup>18</sup>F]ASEM as Radiotracers of Homo- and Heteromeric α7 Nicotinic Acetylcholine ReceptorsCornelius K Donat, Henrik H Hansen, Hanne D Hansen, et al.
Biomaterials|September 29, 2017
Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivoSangmin Lee, Seulhee Jung, Heebeom Koo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancerHong Song, Karineh Shahverdi, David L Huso, et al.
Human Molecular Genetics|January 15, 2013
Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imagingHanna Jaaro-Peled, Minae Niwa, Catherine A Foss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imagingSara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT ImagingRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Clinical Nuclear Medicine|February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human SubjectsRudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Pageof 53

Showing results (391-400 of 525) with videos related to

Sort By:
Pageof 53
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Xin Li, Bruce J Trock, et al.
Angewandte Chemie (International Ed. in English)|July 28, 2015
Synthesis and Evaluation of Gd(III) -Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane AntigenSangeeta Ray Banerjee, Ethel J Ngen, Matthew W Rotz, et al.
Molecules (Basel, Switzerland)|April 5, 2020
In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [<sup>125</sup>I]Iodo-ASEM and [<sup>18</sup>F]ASEM as Radiotracers of Homo- and Heteromeric α7 Nicotinic Acetylcholine ReceptorsCornelius K Donat, Henrik H Hansen, Hanne D Hansen, et al.
Biomaterials|September 29, 2017
Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivoSangmin Lee, Seulhee Jung, Heebeom Koo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancerHong Song, Karineh Shahverdi, David L Huso, et al.
Human Molecular Genetics|January 15, 2013
Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imagingHanna Jaaro-Peled, Minae Niwa, Catherine A Foss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imagingSara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT ImagingRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Clinical Nuclear Medicine|February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human SubjectsRudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Pageof 53